Businesses that manufacture, import, distribute, or otherwise handle products regulated by the Philippine Food and Drug Administration (FDA) may need to secure a license to operate in the Philippines before conducting covered activities.
An FDA License to Operate (LTO) is an establishment authorization. It is different from a product authorization, such as a Certificate of Product Registration (CPR), Certificate of Product Notification (CPN), or medical device authorization. The LTO addresses the establishment and its regulated activities, while the applicable product authorization addresses the products themselves. The FDA’s legal authority to license and monitor establishments and regulate health products comes from Republic Act No. 9711, or the FDA Act of 2009.
The requirements vary depending on the establishment, product category, and activity. Food establishments, pharmaceutical companies, cosmetic businesses, medical device establishments, and household/urban hazardous substance businesses do not necessarily follow identical procedures.
The regulatory framework has also been updated. DOH Administrative Order No. 2024-0015, which took effect on January 12, 2025, repealed AO 2020-0017 and established revised rules for LTO applications of covered health product establishments. The FDA has been migrating different establishment categories into its eServices Portal System through separate implementation issuances.
For companies entering regulated industries, understanding the correct LTO category and application process before beginning operations can prevent avoidable compliance problems.
What Is a License to Operate in the Philippines?
The LTO is an authorization issued by the FDA to covered establishments that allows them to engage in regulated activities within the scope of their authorization.
Republic Act No. 9711 defines licensing as the process of approving an application to operate or establish an establishment before engaging in covered activities involving health products. The law also prohibits the operation of certain covered establishments without the required FDA license.
This makes the LTO an establishment-level requirement rather than simply a registration for one particular product.
For example, a company importing cosmetic products may need an LTO appropriate to its cosmetic establishment activity before it can proceed with cosmetic product notification. The FDA’s current cosmetic product notification checklist requires a valid LTO and specifies applicable establishment activities, such as a cosmetics manufacturer, a cosmetics trader, or a cosmetics distributor importer.
The precise authorization depends on what the company does.
A business should therefore identify its actual activities before selecting an LTO application type.
Which Businesses May Need an FDA LTO?
The FDA regulates establishments involved in activities such as manufacturing, importing, exporting, distributing, trading, and retailing covered health products, depending on the product category and applicable regulations.
Republic Act No. 9711 gives the FDA authority over establishments and health products under its jurisdiction, including manufacturers, importers, exporters, distributors, wholesalers, retailers, and other covered establishments.
The specific establishments subject to licensing vary by regulatory center and product category.
The FDA’s current Citizen’s Charter, for example, lists LTO services for food manufacturers and food traders and distributors, including importers, exporters, and wholesalers. It also identifies LTO services for other regulated establishment categories.
Separate procedures can apply to cosmetics, pharmaceuticals, medical devices, household/urban hazardous substances, and other regulated products.
Businesses should therefore avoid using a generic LTO checklist without first confirming their FDA classification.
Why the LTO Is Separate From Product Registration
One of the most important concepts in Philippine FDA compliance is the distinction between the establishment and the product.
An LTO authorizes the establishment to conduct the regulated activities covered by its license. Product registration or notification determines whether a particular regulated product can be placed on the market under the applicable regulatory framework.
For cosmetics, for example, the FDA states that a Cosmetic Product Notification is issued to licensed establishments, and the application requires a valid LTO with an appropriate cosmetic activity.
A company, therefore, may need both:
Establishment authorization — the appropriate LTO
Product authorization — the authorization applicable to the product category
The two should be planned together because product registration or notification can depend on the establishment’s regulatory status.
The Current LTO Regulatory Framework
Businesses applying today should use the current FDA framework rather than older procedures copied from pre-2025 materials.
DOH Administrative Order No. 2024-0015 repealed AO 2020-0017 and established revised rules governing applications for LTOs of covered health product establishments. The FDA implemented the new framework beginning January 12, 2025, with implementation for specific establishment categories introduced through subsequent advisories.
The transition has been category-specific rather than identical for every establishment.
For example, the FDA announced the onboarding of household/urban hazardous substances establishments into the eServices Portal beginning June 2, 2025, for initial, renewal, and variation LTO applications.
The FDA has also implemented eServices procedures for particular food, pharmaceutical, medical device, and other establishment categories through separate issuances.
This means applicants should confirm whether their specific LTO category has already migrated to the current eServices workflow.
Step 1: Identify the Correct FDA Establishment Category
Correct classification should happen before preparing the application.
A company should determine:
- What products it handles
- Whether it manufactures, imports, distributes, exports, trades, or retails them
- Where the regulated activity occurs
- Whether a warehouse is involved
- Whether the business handles more than one product category
- Whether specialized regulatory rules apply
For cosmetics, for example, the FDA recognizes establishment activities, including manufacturers, traders, and distributor importers, for purposes of product notification.
For food, the FDA provides separate LTO procedures for manufacturers and traders/distributors, including importers, exporters, and wholesalers.
Classification affects the application form, supporting documents, qualified personnel requirements, inspections, and ongoing obligations.
Step 2: Establish the Philippine Business Structure
The FDA application should be consistent with the applicant’s legal business structure.
The company should normally have its Philippine business registration and relevant local operational documents in place before finalizing the FDA application package, subject to the requirements of the particular FDA category.
Corporate applicants may need to provide SEC records, while sole proprietors may use DTI documentation. Local permits may also be relevant to the establishment.
The FDA’s historical and current licensing checklists reflect the importance of establishment identity, address, business registration, and operational information.
This is why the company name and address should remain consistent across business, local, tax, and FDA records.
Step 3: Identify the Qualified Person and Regulatory Personnel
Certain FDA-regulated establishments need qualified personnel who meet the applicable technical requirements.
Under the previous FDA licensing framework, the Qualified Person was defined as an employee with technical competence related to the establishment’s activities and health products through professional qualifications, training, or experience. The specific qualification rules vary by establishment and product category.
The FDA’s newer framework continues to incorporate personnel and technical requirements into establishment licensing, although the exact requirements depend on the establishment type and applicable Annex under AO 2024-0015.
For companies planning an LTO application, the appropriate qualified person should be identified early.
For example, specialized establishments may require a licensed professional or a person with particular academic and technical qualifications.
Businesses should not wait until the filing stage to determine whether their proposed personnel meet the requirements.
Step 4: Prepare the Documentary Requirements
Documentation forms the core of the LTO application.
The precise checklist depends on the establishment category. In general, applicants may be required to provide information concerning:
- Legal business registration
- Establishment address
- Business permit or equivalent document, where applicable
- Ownership or corporate information
- Qualified personnel
- Declared activities
- Warehouse information
- Authorized representatives
- Sources or suppliers
- Products handled
- Required declarations or undertakings
- Proof of payment
- Technical documents required for the specific establishment
The FDA’s published licensing procedures show that documentary requirements differ by establishment type. For food establishments, the current Citizen’s Charter includes different initial, renewal, and variation LTO services for food manufacturers and food traders/distributors.
Some establishment categories may also be subject to inspection-related requirements.
The application should therefore be prepared from the current FDA checklist for the exact business category.
Step 5: Submit the Application Through the FDA’s Online System
The FDA has progressively moved LTO processing into the FDA eServices Portal System.
Under the eServices process, applicants access the relevant application, complete the online form, upload the required documents, and submit the application. The FDA then conducts a pre-assessment of the submitted application and documentary requirements. Where the application passes the applicable pre-assessment stage, the system can issue an Order of Payment to the registered email address.
The actual online pathway depends on whether the establishment category has been onboarded to eServices.
The FDA’s implementation of AO 2024-0015 has occurred through category-specific migration and implementation notices, so businesses should not assume that every establishment follows precisely the same portal workflow.
Step 6: Respond to FDA Deficiencies or Compliance Requests
Submitting the application does not necessarily mean that the LTO will be issued immediately.
The FDA may identify deficiencies or request additional information during review. Applicants must address these matters through the applicable compliance procedure and within the required period.
This is where inconsistent or incomplete information can create delays.
Examples include differences between:
- The registered company name and the FDA application
- The declared address and supporting documents
- The qualified person’s information and submitted credentials
- The business activity and selected LTO category
- The warehouse information and actual operating arrangement
A complete initial submission reduces the risk of repeated corrections.
Step 7: Complete Any Required Inspection
Inspection requirements vary by establishment category, and the current FDA rules applicable to that category.
The FDA’s transition to AO 2024-0015 includes specific inspection arrangements for certain establishment types. For example, the FDA’s 2025 advisory for household/urban hazardous substances states that pre-licensing inspection is required for manufacturers upon an initial LTO or major variation application, while other HUHS establishment categories are subject to the applicable transitional arrangements. Routine or post-licensing inspections also apply.
Businesses should therefore prepare their facilities, records, personnel, and operational procedures based on the applicable inspection requirements rather than assuming every LTO follows the same inspection process.
Where inspection is required, the establishment should be operationally ready before requesting or undergoing the assessment.
What Does the FDA Look For?
The exact inspection agenda depends on the establishment, but companies should generally ensure that their actual operations match what was declared in the application.
Important areas can include:
- Facility and storage conditions
- Product handling procedures
- Documentation and records
- Qualified personnel
- Supplier or source information
- Traceability
- Quality and safety procedures
- Sanitation and housekeeping
- Labeling or product control processes, where applicable
The principle is consistency between documentation and actual operations.
A company should not describe a business model in the application that differs materially from what occurs in the facility.
Cosmetics and the LTO Requirement
Cosmetic businesses are a useful example of how establishment licensing interacts with product authorization.
The Philippine cosmetics framework operates under the ASEAN harmonized regulatory scheme, and the FDA requires covered cosmetic establishments to obtain an LTO before engaging in manufacturing, importation, distribution, and sale of cosmetics.
The FDA’s Cosmetic Product Notification requirements reinforce this relationship. A cosmetic product notification application requires a valid LTO with an appropriate cosmetic establishment activity, such as a cosmetics manufacturer, cosmetics trader, or cosmetics distributor-importer.
For businesses entering the cosmetics market, this means establishment licensing should be planned before product notification.
It also means a company should determine whether its actual role is manufacturer, trader, distributor importer, or another applicable category before submitting the LTO application.
Food Businesses and the LTO
Food businesses follow their own FDA requirements, and the appropriate LTO category depends on the establishment’s activity.
The FDA’s current Citizen’s Charter lists separate LTO services for food manufacturers and food traders/distributors, including importers, exporters, and wholesalers of covered processed food products, food supplements, bottled water, and iodized salt.
A food company should therefore identify whether it is manufacturing, trading, importing, exporting, or wholesaling rather than selecting a generic food LTO.
Additional food regulatory requirements may apply depending on the product and activity.
Renewal and Variation of an LTO
Obtaining the original license is not the end of regulatory compliance.
The FDA provides processes for initial, renewal, and variation applications. The current regulatory framework treats changes to an establishment’s circumstances through variation procedures where applicable. The FDA’s implementation advisory for HUHS establishments, for example, expressly identifies initial, renewal, and variation applications and provides separate procedures for each.
A variation may become relevant when information reflected in the LTO changes.
Depending on the establishment, this can involve changes relating to:
- Establishment information
- Address
- Activities
- Sources
- Products
- Qualified personnel
- Warehouses
- Other approved details
The exact classification of a change as major or minor depends on the applicable regulatory rules.
Businesses should therefore report relevant changes instead of continuing to operate indefinitely under outdated FDA information.
What Happens After the LTO Is Issued?
The LTO creates continuing compliance responsibilities.
Republic Act No. 9711 gives the FDA authority to inspect establishments, monitor health products, require reporting of certain incidents, issue enforcement actions, and conduct post-market surveillance.
This means the company should maintain the conditions under which its authorization was issued.
For an operating business, ongoing compliance can include:
- Maintaining the required personnel
- Keeping establishment records updated
- Maintaining proper product and supplier documentation
- Complying with applicable reporting obligations
- Monitoring product quality
- Managing changes through the appropriate FDA process
- Preparing for inspections
- Renewing the LTO when required
The LTO should therefore be treated as part of the company’s regulatory management system rather than as a document obtained once and forgotten.
How Businesses Can Prepare for a License to Operate Application
Preparation should begin before the company submits anything to the FDA.
Start by identifying the regulated products and defining the establishment’s role in the supply chain. Determine whether the company manufactures, imports, distributes, trades, exports, or retails the products.
Next, establish the Philippine business structure and operating location. Confirm that the registered business information, local permits, and facility information are consistent.
Then identify the qualified personnel and assemble the documentation required for the specific FDA category.
Before submission, conduct an internal review of the application as if it were being assessed by the FDA. Confirm that the declared activity matches the actual operation, that all supporting documents are current, and that the facility is ready for any applicable inspection.
Finally, establish a compliance calendar for renewals, variations, inspections, and product-related authorizations.
Final Perspective
Securing a license to operate in the Philippines is an important regulatory step for businesses handling products under FDA jurisdiction. The requirement applies to establishments, and the exact LTO pathway depends on the business activity, product category, and applicable FDA rules.
The regulatory environment has changed significantly with DOH Administrative Order No. 2024-0015, which repealed AO 2020-0017 and took effect on January 12, 2025. The FDA has been migrating establishment categories to its eServices Portal under separate implementation advisories, so businesses should confirm the current process for their particular category.
Applicants should also distinguish the LTO from product authorization. An establishment may need an LTO before it can proceed with the applicable product registration or notification. This relationship is particularly clear for cosmetics, where a valid cosmetic LTO is required for cosmetic product notification.
The most effective approach is to begin with accurate classification, prepare complete documentation, identify qualified personnel, submit through the applicable FDA system, respond promptly to deficiencies, and maintain compliance after approval.
Businesses should also plan for renewal and variations because the information and activities covered by an LTO may change over time.
For companies entering the Philippine market with regulated products, proper LTO planning can help integrate FDA compliance with broader business registration, importation, product authorization, and commercial launch activities.
Is Assistance Available?
Yes. Triple i Consulting provides FDA consulting services for businesses seeking a license to operate in the Philippines and related regulatory authorizations. Triple i Consulting’s services support businesses dealing with FDA-regulated products and can help coordinate establishment licensing, product registration, and other FDA compliance requirements.
Triple i Consulting can assist with assessing the appropriate FDA establishment category, preparing documentary requirements, coordinating applications, and addressing related regulatory requirements based on the company’s activities and products.
For assistance with securing a license to operate in the Philippines and related FDA requirements, contact our team to schedule an initial consultation:
- Contact Us Here
- Fill out the form below
- Call us at: +63 (02) 8540-9623
- Send an email to: info@tripleiconsulting.com
